Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Lantheus Holdings (LNTH)

Lantheus Holdings (LNTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 823,816
  • Shares Outstanding, K 39,248
  • Annual Sales, $ 343,370 K
  • Annual Income, $ 40,520 K
  • 60-Month Beta 1.46
  • Price/Sales 2.46
  • Price/Cash Flow 15.80
  • Price/Book 8.10

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.31
  • Number of Estimates 1
  • High Estimate 0.31
  • Low Estimate 0.31
  • Prior Year 0.24
  • Growth Rate Est. (year over year) +29.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.34 +14.45%
on 10/14/19
21.84 -3.89%
on 11/12/19
+2.00 (+10.53%)
since 10/11/19
3-Month
17.85 +17.59%
on 10/08/19
27.12 -22.60%
on 09/24/19
-1.26 (-5.66%)
since 08/12/19
52-Week
13.82 +51.88%
on 12/24/18
29.80 -29.56%
on 07/01/19
+6.13 (+41.25%)
since 11/12/18

Most Recent Stories

More News
Lantheus Releases Comprehensive Strategic Plan for Progenics

--Lantheus' In-Place Infrastructure and Commercial Capabilities Will Ensure the Progress of AZEDRA, and the PyL and 1095 Programs

LNTH : 20.99 (-2.51%)
Lantheus Holdings (LNTH) Tops Q3 Earnings and Revenue Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 12.00% and 2.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

LNTH : 20.99 (-2.51%)
Lantheus Holdings: 3Q Earnings Snapshot

NORTH BILLERICA, Mass. (AP) _ Lantheus Holdings Inc. (LNTH) on Thursday reported third-quarter net income of $4.9 million.

LNTH : 20.99 (-2.51%)
Lantheus Holdings, Inc. Reports Third Quarter 2019 Financial Results

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative diagnostic...

LNTH : 20.99 (-2.51%)
Lantheus Holdings to Present at the Credit Suisse 28th Annual Healthcare Conference

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. ("LMI"), a global leader in the development, manufacture and commercialization of innovative...

LNTH : 20.99 (-2.51%)
Progenics Strongly Agrees With ISS Recommendation that Velan Group SHOULD NOT Get Majority Control of the Board of Directors

ISS Recognizes that Shareholders Should Have Full Information About the Lantheus Transaction Before Making Significant Decisions About the Company

PGNX : 5.77 (+2.49%)
LNTH : 20.99 (-2.51%)
Progenics Highlights Additional Serious Concerns About Velan Capital, L.P.

Flags Velan's Knowledge of Lantheus Transaction Weeks Before It Was Made Public

PGNX : 5.77 (+2.49%)
LNTH : 20.99 (-2.51%)
Lantheus Holdings to Host Third Quarter 2019 Earnings Conference Call on October 31, 2019 at 8:00 a.m. Eastern Time

Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH) today announced that it will host a conference call at 8:00 a.m. ET on Thursday, October 31, 2019, to discuss its financial and operating results...

LNTH : 20.99 (-2.51%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds HLND, TNCB, PGNX, DOVA Shareholders About Its Ongoing Investigations

EQNX::TICKER_START (OtherOTC:HLND),(PinkSheets:TNCB),(NASDAQ:PGNX),(NASDAQ:DOVA),(NASDAQ:FCBC),(NASDAQ:RBNC),(NASDAQ:LNTH),(Nasdaq First North Sweden:SOBI), EQNX::TICKER_END

HLND : 8.3900 (-0.71%)
FCBC : 31.83 (-0.44%)
RBNC : 22.52 (-0.27%)
PGNX : 5.77 (+2.49%)
LNTH : 20.99 (-2.51%)
DOVA : 28.04 (+0.14%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Progenics Pharmaceuticals, Inc. ("Progenics" or the "Company") (NASDAQ: PGNX) in connection...

PGNX : 5.77 (+2.49%)
LNTH : 20.99 (-2.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade LNTH with:

Business Summary

Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations,...

See More

Key Turning Points

2nd Resistance Point 22.22
1st Resistance Point 21.61
Last Price 20.99
1st Support Level 20.61
2nd Support Level 20.22

See More

52-Week High 29.80
Fibonacci 61.8% 23.70
Fibonacci 50% 21.81
Last Price 20.99
Fibonacci 38.2% 19.92
52-Week Low 13.82

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar